lines (L1210 and PC13) using the MTT assay. After 72 hours
of incubation, each compound showed moderate growth-
inhibitory activity toward these cells (ESIw, Table S4). 2 was
then subjected to the trypan blue dye exclusion using HL60
human leukemia cells, and showed cytotoxicity (IC50 value:
0.60 mg mlÀ1). In addition, 2-induced cell death in HL60 cells
was suppressed in the presence of Z-VAD-FMK, an irrever-
sible and cell-permeable inhibitor of caspases (Fig. 4A). DNA
ladder analysis revealed that 2 induced DNA fragmentation in
HL60 cells (Fig. 4B). These results indicated that 2 induced
apoptosis in HL60 cells.
In conclusion, we isolated halichonines A (1), B (2), and C
(3) from the marine sponge H. okadai Kadota. Based on the
results of spectroscopic analyses, 1–3 were determined to be
novel sesquiterpene alkaloids with a 6,6-bicyclic ring system
possessing different levels of oxidation at position C3. In
addition, the relative stereostructure of 1 was confirmed by
successful synthesis. All three halichonine congeners showed
growth-inhibitory activities against mammalian cancer cells,
and 2 was revealed to induce apoptosis in HL60 cells. Thus,
these halichonines may deserve further studies.
Scheme 1 Total synthesis of (Æ)-1. Reagents and conditions: (a)
Boc2O (1.2 equiv.), Et3N (1.2 equiv), CH2Cl2, rt. (b) 1-bromo-3-
methyl-2-butene (3.0 equiv.), K2CO3 (2.5 equiv.), DMF, rt, 77% yield
for 2 steps. (c) TFA, CH2Cl2, 0 1C, 54% yield. (d) BAIB (1.2 equiv.),
TEMPO (0.1 equiv.), 69% yield. (e) 6 (2.7 equiv.), NaBH(OAc)3 (5.0
equiv.), DCE, rt, 44% yield. (f) 3-methyl-2-butenal (2.5 equiv.),
NaBH(OAc)3 (5.0 equiv.), DCE, rt, 32% yield. (g) PhSH (1.3 equiv.),
K2CO3 (2.3 equiv.), CH3CN, rt, 14% yield.
We thank Drs T. Sasamori, Kyoto University, K. Naka-
mura, Kanagawa University, Y. Yamano, Osaka University,
and K. Miyamoto, Keio University, for their contributions to
our studies. This work was supported in part by Grants-in-Aid
from the Ministry of Education, Culture, Sports, Science and
Technology of Japan (21221009 to D.U. and 20611006
to O.O.).
Notes and references
1 G. Vogel, Science, 2008, 320, 1028.
2 K. Tachibana, P. J. Scheuer, Y. Tsukitani, H. Kikushi,
D. V. Engen, J. Clardy, Y. Gopichand and F. J. Schmitz, J. Am.
Chem. Soc., 1981, 103, 2469.
3 (a) D. Uemura, K. Takahashi, T. Yamamoto, C. Katayama,
J. Tanaka, Y. Okumura and Y. Hirata, J. Am. Chem. Soc., 1985,
107, 4796; (b) Y. Hirata and D. Uemura, Pure Appl. Chem., 1986,
58, 701.
4 (a) M. Kuramoto, T. Chou, K. Yamada, T. Chiba, Y. Hayashi and
D. Uemura, Tetrahedron Lett., 1996, 37, 3867; (b) S. Xu,
H. Yoshimura, N. Maru, O. Ohno, H. Arimoto and D. Uemura,
J. Nat. Prod., 2011, 74, 1323.
Fig. 4 Induction of apoptosis in HL60 cells by 2. (A) HL60 cells were
preincubated (solid column) or not (open column) with 50 mM
Z-VAD-FMK, and then treated with 0 or 1 mg mlÀ1 of 2. After
24 h, cell viability was determined. Values are the means Æ SD of
quadruplicate determinations. (B) HL60 cells were incubated with the
indicated concentrations of 2 for 24 h. Cellular DNA was then
extracted and electrophoresed on an agarose gel.
5 (a) M. J. Towle, K. A. Salvato, J. Budrow, B. F. Wels,
G. Kuznetsov, K. K. Aalfs, S. Welsh, W. Zheng, B. M. Seletsky,
M. H. Palme, G. J. Habgood, L. A. Singer, L. V. Dipietro,
Y. Wang, J. J. Chen, D. A. Quincy, A. Davis, K. Yoshimatsu,
Y. Kishi, M. J. Yu and B. A. Littlefield, Cancer Res., 2001,
61, 1013; (b) T. K. Huyck, W. Gradishar, F. Manuguid and
P. Kirkpatrick, Nat. Rev. Drug Discovery, 2011, 10, 173.
6 (a) D. Uemura, Chem. Rec., 2006, 6, 235; (b) D. Uemura, Proc.
Jpn. Acad., Ser. B, 2010, 86, 190.
7 See the ESIw.
8 W. Moffitt, R. B. Woodward, A. Moscowitz, W. Klyne and
C. Djerassi, J. Am. Chem. Soc., 1961, 83, 4013.
9 T. Fukuyama, J. Chung-Kuang and C. Mui, Tetrahedron Lett.,
1995, 36, 6373.
(Æ)-3b-Hydroxydrimenol (7) was prepared in 5 steps from
farnesol as previously reported.10 Oxidation of 7 with BAIB
and a catalytic amount of TEMPO gave aldehyde 8 (78% yield)
as a colorless oil.11 The aldehyde 8 was then subjected to
reductive amination with 6, to give amine 9 (44% yield).12
Reductive amination of 9 with 3-methyl-2-butenal afforded 10
in 32% yield. The nosyl protecting group of 10 was removed with
PhSH and K2CO3 to give (Æ)-1 and unidentified byproducts.
Finally, purification of the mixture using alumina column chromato-
graphy (hexane/EtOAc, CHCl3, and CHCl3/MeOH) provided
(Æ)-1 in 14% yield (Scheme 1). Synthetic 1 was identical to the
natural 1 in all respects (1H and 13C NMR, and HR-ESIMS
spectra). Thus, the relative stereostructure of 1 was confirmed.
Next, compounds 1–3 were examined with regard to their
growth-inhibitory activities against mammalian cancer cell
10 W. A. Ayer and P. A. Craw, Can. J. Chem., 1989, 67, 1371.
11 A. De Mico, R. Margarita, L. Parlanti, A. Vescovi and
G. Piancatelli, J. Org. Chem., 1997, 62, 6974.
12 A. F. Abdel-Magid, K. G. Carson, B. D. Harris, C. A. Maryanoff
and R. D. Shah, J. Org. Chem., 1996, 61, 3849.
c
This journal is The Royal Society of Chemistry 2011
Chem. Commun., 2011, 47, 12453–12455 12455